Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success
admin Next stop regulatory approval. That was the view of analysts at Mizuho Securities, who late…
Read MoreHealth
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker and…
Read MoreAlzheimer’s drug from Eisai, Biogen shows promise in large trial
Eisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug…
Read MoreAirport and airline workers speak out worldwide about ‘ridiculous’ conditions
Airport and airline workers staged demonstrations at airports across the U.S. and abroad Tuesday, protesting…
Read MoreCal-Maine says avian flu could continue to hit egg supplies after this year
Shares of Cal-Maine Foods Inc. edged lower in the extended session Tuesday after the largest…
Read More‘The motivation was greed’: Ex-Nigerian official gets 5 years for stealing US disaster funds
A former government official in Nigeria has been sentenced to five years in a U.S.…
Read MoreMedicare premiums are decreasing in 2023 – this is how much older Americans will save if they’re on Part B
Medicare beneficiaries will see their Part B premiums go down for the first time in…
Read MoreOpinion: Tweak the Affordable Care Act to mandate backstop health insurance
Universal health coverage in the U.S.—once considered a hopeless goal without imposing a single payer…
Read MoreThe pandemic didn’t stop college-educated women from surpassing men in the U.S. workforce
There’s been one notable labor-market turnaround since the worst days of the COVID-19 pandemic —…
Read More
My daughter died from a drug overdose, and two of her kids were raised by their other grandparents. I’m leaving my house to my son’s child. Is that fair?
My husband recently died and I am in the process of getting the financial paperwork…
Read More